News and Updates

Mabwell has received FDA approval for the clinical trial of its novel injection, 6MW5311. Learn about this major development in drug innovation.

The FDA has approved the clinical trial application for Mabwell’s 6MW5311 injection. Learn more about this new development in targeted biologic therapy.

Algenomics reports promising interim data for RZ-001 in treating recurrent glioblastoma. Discover the latest clinical updates from the ASNO conference.

New research suggests a common laxative may help treat cognitive "brain fog" in depressed patients by targeting the gut-brain axis. Read the latest findings.

New Phase 2 results reveal high efficacy for Qurucell’s Limcato CAR-T therapy, showing promising remission rates for patients with refractory blood cancer.

Discover the new medical drama 'The F Ward' starring Anna Friel. Get the latest on the series launch, plot, and its portrayal of real-world hospital life.

Rocket Pharmaceuticals sells its FDA Priority Review Voucher for $180M. Learn how this strategic divestiture boosts gene therapy R&D and market liquidity.

United Laboratories has gained approval for its new TUL321 clinical trial. Discover how this development impacts the company's valuation and R&D outlook.

An Ahmedabad retiree lost ₹1.21 crore to a sophisticated stock market scam. Learn how to spot fake trading apps and protect your investments from fraud.

The DRC reports nearly 600 Ebola cases, prompting global health alerts regarding regional transmission risks and the urgent need for enhanced containment efforts.